Latest From CryoLife Inc.
The disruptive medtech M&A of recent years was not matched in the past year for volume, but there were isolated outbreaks of major activity, as shown in our company rankings.
Israeli healthtech fund Accelmed is raising $100m for its fourth fund focused on medical device and digital health companies.
Device fundraising during the fourth quarter totaled $2.6 billion, making it the strongest quarter of the year. Q4 M&A activity reached $3.9 billion, higher than Q3's $3.4 billion, but still one of the lowest quarters of the year. Both fourth quarter diagnostics financings and M&As hit an all-year low of $622 million, and $2.8 million, respectively.
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in October 2017.
- Implantable Devices
- Therapeutic Areas
- North America
- Parent & Subsidiaries
- CryoLife Inc.
- Senior Management
Pat G Mackin, Chmn., Pres. & CEO
D. Ashley Lee, EVP, COO & CFO
David C Gale, PhD, VP, R&D
John Davis, SVP, Global Sales & Mktg.
- Contact Info
Phone: (770) 419-3355
1655 Roberts Blvd., NW
Kennesaw, GA 30144
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.